Defining the Role of ABI1 Gene in Prostate Cancer Progression and Treatment Resistance

This study explores the role of the ABI1 gene in prostate cancer progression and treatment resistance, particularly in the context of anti-androgen receptor (AR) therapies. The research identifies a novel mechanism of resistance involving ABI1, an actin regulatory protein, which is directly regulated by androgens and interacts with AR and its splice variant ARv7. This interaction co-regulates specific transcriptional targets, linking the actin cytoskeleton, cellular signaling, and transcriptional regulation. The findings suggest that ABI1 acts as an epigenetic regulator in AR-driven cancers, offering potential for innovative therapies targeting transcriptional dysregulation in prostate cancer.